NL-OMON23023尚未招募不适用
TARC-002 EVALUATION OF THYMUS AND ACTIVATION REGULATED CHEMOKINE (TARC) IN PATIENTS WITH LYMPHADENOPATHY , FEVER OR NON-HODGKIN LYMPHOMA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Age ¡Ý 18 years; - Ability to give written informed consent; And one of the following: (1) Lymph node enlargement of unknown cause for whicha diagnostic fine needle aspiration will be performedor (2) Presenting with fever at the emergency department or (3) Presenting with newly diagnosed or relapsed nodular lymphocyte predominant or non-Hodgkin lymphoma.
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study (applicable to all subgroups): - Ineligibility to give written informed consent; - Patients with active atopic disease or hepatic failure; - Patients already diagnosed with Hodgkin lymphoma
研究者
相似试验
已完成
不适用
TARC-002 EVALUATION OF THYMUS AND ACTIVATION REGULATED CHEMOKINE (TARC) IN PATIENTS WITH LYMPHADENOPATHY , FEVER OR NON-HODGKIN LYMPHOMAlymphomaNL-OMON45645niversitair Medisch Centrum Groningen300
进行中（未招募）
1 期
A research study to evaluate the activity of the drug trabectedin in patients with a lung cancer called mesotheliomaMalignant Pleural MesotheliomaEUCTR2011-006330-16-ITIstituto di ricerche farmacologiche Mario Negri145
进行中（未招募）
1 期
A study evaluating the effect of a chemotherapy regimen on the menstrual and ovarian functions of young breast cancer patientsEUCTR2013-000173-77-BEInstitut Jules Bordet50
已完成
2 期
A PHASE II EVALUATION OF TEMSIROLIMUS (CCI-779) (NCI SUPPLIED AGENT:NSC# 683864, IND# 61010) IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL FOLLOWED BY TEMSIROLIMUS (CCI-779) CONSOLIDATION AS FIRST-LINE THERAPY IN THE TREATMENT OF STAGE III-IV CLEAR CELL CARCINOMA OF THE OVARYStage III or IV clear cell ovarian cancerJPRN-jRCT2091220076Gynecologic Oncology Group45
已完成
4 期
THE TREMOR STUDY: TACROLIMUS EXTENDED RELEASE, MOVEMENT DISORDERS AND OTHER NEUROCOGNITIVE EFFECTSkidney transplantation10029149NL-OMON43508Academisch Medisch Centrum66